Explore
Validate
LearnMA1-41181
antibody from Invitrogen Antibodies
Targeting: ARHGDIB
GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [2]
- Flow cytometry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-41181 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- D4-GDI Monoclonal Antibody (10D774)
- Antibody type
- Monoclonal
- Antigen
- Synthetic peptide
- Description
- Suggested positive control: antigen standard for ARHGDIB (transient overexpression lysate), Daudi or Jurkat.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 10D774
- Vial size
- 100 µg
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of D4-GDI in Jurkat cells. Samples were incubated in D4-GDI monoclonal antibody (Product # MA1-41181 using a dilution of 2 µg/mL. D4-GDI (cleavage specific) at 0.1 µg/mL. Cells were treated with 2 µM staurosporine for different time periods. Detects both the full-length and cleaved forms of D4GDI while D4-GDI (cleavage specific) specifically detects only the cleaved form of the protein.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of D4-GDI in whole Jurkat cell lysate. Sample was incubated in D4-GDI monoclonal antibody (Product # MA1-41181).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- HL60 cells were left untreated (green) or treated with camptothecin to induce apoptosis (red). Cells were analyzed by intracellular flow cytometry using either the a D4 GDI monoclonal antibody (Product # MA1-41085) or a D4 GDI monoclonal antibody (Product # MA1-41181) (0.5 µg antibody/test/1 million cells). A: a D4 GDI monoclonal antibody (Product # MA1-41085) which recognizes only cleaved D4-GDI. B: a D4 GDI monoclonal antibody (Product # MA1-41085) which recognizes both full-length and cleaved D4-GDI. The results in (A) show that the untreated cell population was primarily negative for cleaved D4-GDI (Product # MA1-41085) whereas the treated population was primarily positive. This is because D4-GDI is cleaved in cells undergoing apoptosis but is present as a full-length form in normal cells. Hence the cleavage specific D4-GDI antibody (Product # MA1-41085) does not recognize very many cells in the untreated population. There may be a small percentage of positive cells in untreated populations due to a basal level of apoptosis. In contrast both the untreated and treated cell populations were positive for D4-GDI using Product # MA1-41181 (as seen in B). This is because it recognizes both the full-length (cells not undergoing apoptosis) and cleaved (apoptotic cells) forms of D4-GDI.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Flow cytometry of D4-GDI in HL60 cells untreated (green) or treated with camptothecin to induce apoptosis (red). Samples were incubated in D4-GDI monoclonal antibody (Product # MA1-41181) using a dilution of 0.5 µg antibody/test/1 million cells. A: D4-GDI antibody (clone: 97A1015) which recognizes only cleaved D4-GDI. B: This antibody (clone: 10D774) which recognizes both full-length and cleaved D4-GDI.
